Crawford Announces New Ad Policy Group, Defends FDA Court Interventions
This article was originally published in The Gray Sheet
Executive Summary
An FDA intercenter coordinating group will oversee medical product advertising to ensure it is properly regulated, according to Acting Commissioner Lester Crawford, PhD/DVM